345 related articles for article (PubMed ID: 36235023)
1. Metallo-Drugs in Cancer Therapy: Past, Present and Future.
Lucaciu RL; Hangan AC; Sevastre B; Oprean LS
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235023
[TBL] [Abstract][Full Text] [Related]
2. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
Lazarević T; Rilak A; Bugarčić ŽD
Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
[TBL] [Abstract][Full Text] [Related]
3. Anticancer metallodrugs: where is the next cisplatin?
Hanif M; Hartinger CG
Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
[TBL] [Abstract][Full Text] [Related]
4. Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy.
Li ZY; Shen QH; Mao ZW; Tan CP
Chem Asian J; 2022 Jul; 17(13):e202200270. PubMed ID: 35419865
[TBL] [Abstract][Full Text] [Related]
5. Addressing the gaps in homeostatic mechanisms of copper and copper dithiocarbamate complexes in cancer therapy: a shift from classical platinum-drug mechanisms.
Njenga LW; Mbugua SN; Odhiambo RA; Onani MO
Dalton Trans; 2023 May; 52(18):5823-5847. PubMed ID: 37021641
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy.
Abid M; Shamsi F; Azam A
Mini Rev Med Chem; 2016; 16(10):772-86. PubMed ID: 26423699
[TBL] [Abstract][Full Text] [Related]
7. New applications of old metal-binding drugs in the treatment of human cancer.
Schmitt SM; Frezza M; Dou QP
Front Biosci (Schol Ed); 2012 Jan; 4(1):375-91. PubMed ID: 22202066
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
Zhang X; Liu D; Lv F; Yu B; Shen Y; Cong H
Colloids Surf B Biointerfaces; 2019 Oct; 182():110373. PubMed ID: 31376689
[TBL] [Abstract][Full Text] [Related]
9. Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?
Kenny RG; Marmion CJ
Chem Rev; 2019 Jan; 119(2):1058-1137. PubMed ID: 30640441
[TBL] [Abstract][Full Text] [Related]
10. Advances in anticancer alkaloid-derived metallo-chemotherapeutic agents in the last decade: Mechanism of action and future prospects.
Ansari MF; Khan HY; Tabassum S; Arjmand F
Pharmacol Ther; 2023 Jan; 241():108335. PubMed ID: 36567056
[TBL] [Abstract][Full Text] [Related]
11. Metal Complexes in Cancer Treatment: Journey So Far.
Kumar Singh A; Kumar A; Singh H; Sonawane P; Pathak P; Grishina M; Pal Yadav J; Verma A; Kumar P
Chem Biodivers; 2023 Apr; 20(4):e202300061. PubMed ID: 36824028
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems.
Ferraro MG; Piccolo M; Misso G; Maione F; Montesarchio D; Caraglia M; Paduano L; Santamaria R; Irace C
Cells; 2020 Jun; 9(6):. PubMed ID: 32517101
[TBL] [Abstract][Full Text] [Related]
13. Noble metal-dithiocarbamates precious allies in the fight against cancer.
Nagy EM; Ronconi L; Nardon C; Fregona D
Mini Rev Med Chem; 2012 Oct; 12(12):1216-29. PubMed ID: 22931593
[TBL] [Abstract][Full Text] [Related]
14. Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity.
Leon IE; Cadavid-Vargas JF; Di Virgilio AL; Etcheverry SB
Curr Med Chem; 2017; 24(2):112-148. PubMed ID: 27554807
[TBL] [Abstract][Full Text] [Related]
15. Recent development of transition metal complexes with in vivo antitumor activity.
Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
[TBL] [Abstract][Full Text] [Related]
16. Targeting copper in cancer therapy: 'Copper That Cancer'.
Denoyer D; Masaldan S; La Fontaine S; Cater MA
Metallomics; 2015 Nov; 7(11):1459-76. PubMed ID: 26313539
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances on Dark and Light-Activated Cytotoxity of Imidazole-Containing Ruthenium Complexes.
Liu P; Jia J; Zhao Y; Wang KZ
Mini Rev Med Chem; 2016; 16(4):272-89. PubMed ID: 26586123
[TBL] [Abstract][Full Text] [Related]
18. A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies.
Adhikari S; Nath P; Das A; Datta A; Baildya N; Duttaroy AK; Pathak S
Biomed Pharmacother; 2024 Feb; 171():116211. PubMed ID: 38290253
[TBL] [Abstract][Full Text] [Related]
19. Metal complexes in medicine and pharmacy - the past and the present II.
Habala L; Valentová J
Ceska Slov Farm; 2020; 69(1):3-16. PubMed ID: 32460505
[TBL] [Abstract][Full Text] [Related]
20. Editorial: Anticancer Ruthenium Complexes in Drug Discovery and Medicinal Chemistry.
Thota S
Mini Rev Med Chem; 2016; 16(10):771. PubMed ID: 27161007
[No Abstract] [Full Text] [Related]
[Next] [New Search]